Vie Ventures

In the news.

Coverage, announcements, and conversations from across the Vie Ventures ecosystem.

Investing in a Cure

Steven St. Peter discusses how venture philanthropy, impact investing and venture capital can work together to support IBD innovation.

Vie VenturesNov 16, 2026

Vie Ventures at FASI-10 Summit: Challenges and Opportunities in Food Allergy Drug Development

Vie VenturesOct 24, 2026

Luke Evnin at Cool Comedy • Hot Cuisine

Vie VenturesOct 13, 2026

Jeff Bluestone Honored with the 2026 UCSF Medal

Jeff Bluestone receives UCSF’s highest honor in recognition of his contributions to immunology and the translation of scientific discoveries into new therapies.

Vie VenturesSep 11, 2026

Boom Times For Autoimmune Disease Therapies

ForbesJul 8, 2026

Food Allergy Science Initiative and Vie Ventures Announce Strategic Collaboration to Accelerate Progress Toward a Cure for Food Allergies

Business WireJun 23, 2026

Vie Ventures Looks To Fill Autoimmune Disease Funding Gap

In VivoMay 19, 2026

20 Voices: What Does 2026 Hold For Biopharma?

In VivoFeb 23, 2026

Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio

BioCenturyFeb 19, 2026

Vie Ventures Names Jeff Bluestone, PhD, as Managing Director

Vie VenturesFeb 19, 2026

Interview with Vie Ventures Co-Founders Dr. Steven St. Peter and Dr. Luke Evnin and Senior Advisor Dr. Louis DeGennaro

Close EncountersJan 21, 2026

Catalytic Capital in Biotech & VC Philanthropy: Redefining purpose-aligned capital

YouTubeDec 17, 2025

Two veterans from MPM launch Vie Ventures to invest in the I&I space, leveraging disease-specific philanthropies

BioTech TVDec 5, 2025

A Venture Fund that Leverages Patient Experts to Target Autoimmune Diseases

Global Genes · RARECastNov 26, 2025

Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems

Vie VenturesSep 17, 2025

Therapeutics Advisory Council Seeks to Drive Innovation in Autoimmune Disease Treatment

Vie Ventures BlogSep 16, 2025

Vie Ventures Launches to Bankroll Autoimmune-Disease Biotechs

The Wall Street JournalJul 9, 2025

Veteran venture capitalists launch new firm to Vie for autoimmune success

FierceBiotechJul 9, 2025

Vie Ventures, New Life Sciences Venture Capital Firm, Launches to Advance Next Generation Therapies for Autoimmune Diseases

Vie VenturesJul 9, 2025

Building the future of autoimmune therapeutics.

Whether you are a prospective investor, a strategic collaborator, or a company creating next-generation therapies, we would be glad to connect.

Or email us directly at contact@vieventures.com.